AXC
AxellaCoin
Powering innovation in clinical research through blockchain
What is AxellaCoin?
AxellaCoin (AXC) is a Cardano-native utility token developed by Axella Research to fund early-stage biotech innovation — including compassionate use and expanded access clinical trials.AXC allows researchers, clinicians, and communities to support meaningful real-world impact through decentralized funding.
AXC Policy# 90b43f663f18ab184209e9235365c282dd18a74aceacc59fcf9e2a0e
How It Works
• Fund real-world clinical trials using AXC
• Earn fees by becoming a liquidity provider
• Access early-stage biotech research
• Future: Vote on trial grants via AXC governance
• Support compassionate use clinical trials that provide investigational treatment access to patients with no standard care options.
How to Get AXC
1. Visit Minswap and connect your Cardano wallet (Eternl, Nami, etc.)
2. Swap ADA for AXC
3. (Optional) Add liquidity to earn rewards
Join the AXC Vendor Pioneer Program
🚀 Power Clinical Research with Every Invoice
By accepting just 10% of your invoice in AxellaCoin (AXC), you’ll be doing more than getting paid — you’ll be helping fund the next generation of clinical trials.This pilot program is designed for our trusted vendors and service partners who want to support medical innovation with minimal friction and real upside.
Backed by Axella Research
Axella Research is a U.S.-based Contract Research Organization (CRO) that supports biotech startups with early-phase clinical trials. Our goal is to decentralize trial funding while maintaining scientific and regulatory integrity.
Support Compassionate Use Trials
AxellaCoin (AXC) is pioneering a decentralized fund to support compassionate use and expanded access clinical trials — helping patients gain earlier access to investigational treatments when no other options remain.If you're a patient, physician, sponsor, or biotech team seeking a compassionate use protocol, we want to support you with non-dilutive funding, regulatory assistance, and optional CRO collaboration.
🎯 Stake AXC to Support a Clinical Trial
📥 Stake-to-Support Program
Support real-world clinical trials by staking AXC and earn milestone-based rewards.🔹 Buy AXC on Minswap
Use a Cardano wallet like Eternl or Nami to purchase AXC.🔹 Staking Wallet Address:addr1q86c9dmz3yh6xgq9cje8q6wvf2kdy8cl4qry5edzwd436mgew9ezf787q8rv0l8aumnhqgyzjmnqw03mafsrzn4wxapqthrd3vMinimum stake: 500 AXC
Save your transaction ID (TxID) after sending.🔹 Submit the Stake Form
Log your stake, select the trial you're supporting, and become eligible for milestone-based AXC rewards.Want to be recognized as a supporter?
Include your name or alias in the form — it will be displayed on our Public Dashboard
AXC Dashboard
📊 AXC Transparency DashboardStay informed about AxellaCoin’s token usage and funding progress in real time.----🔹 Dashboard Summary
A live snapshot of circulating supply, treasury balance, and trials funded.🔹 Token Allocation Details
Breakdown of how AXC is allocated across liquidity, staking, trials, and reserves.🔹 Circulating Supply Tracker
Track AXC released to the public and its categories over time.🔗 All links open in a new tab
AXC Equity-Backed Research Funding Model
To scale its impact and sustainability, AxellaCoin (AXC) will introduce a milestone-based funding model where AXC is used to support early-stage biotech companies — with structured upside flowing back into the AXC treasury.As AXC token value increases, a predetermined amount of AXC will be unlocked to fund clinical trials and translational research. When funding is directed to emerging biotech startups, AXC will enter into agreements that secure financial participation in the form of equity, warrants, or royalty rights.Example: AXC will provide early-stage funding to a biotech developing stem cell therapies across several indications. In return, the AXC treasury will receive equity warrants or convertible rights.These upside positions will be held in a secure legal entity governed by Axella Research or the AXC DAO. Any realized gains (e.g., company acquisition, IPO, or out-licensing) will be cycled back into the AXC treasury and redeployed to fund future clinical research initiatives.This creates a value-aligned feedback loop:
1. AXC funds clinical innovation
2. Biotech success drives financial returns
3. Returns strengthen the treasury
4. More trials are funded without depleting reservesOver time, this model will allow AXC to become a self-sustaining, community-powered biotech launchpad.
🔓 AXC Milestone Unlock PlanTo preserve token scarcity while scaling research funding, AXC unlocks are triggered by transparent milestones such as price targets and DAO votes.As the market price of AxellaCoin (AXC) increases, additional tokens are unlocked from the AXC Grant Vault to fund clinical trials. Each milestone enables larger-scale, high-impact research — including rare disease studies, first-in-human trials, and biotech equity programs. This ensures that token growth directly fuels patient access and scientific progress.View the full Milestone Unlock Plan below:🔗 View Full Milestone Unlock Table
🏛 AXC Governance & Compliance ManualAxellaCoin (AXC) is committed to transparency, integrity, and responsible token governance. Our combined Governance, Compliance & Trial Funding Framework outlines:🔹Treasury and vesting structures🔹Anti-manipulation and fair trading policies🔹Grant funding logic and staking-based trial support🔹Legal disclosures on token valuation and tax treatmentThis unified manual reflects the safeguards and strategies that protect the AXC ecosystem and align stakeholders with our long-term mission to revolutionize clinical research funding.👉 View the Full AXC Governance & Compliance Manual
Advisory Board
Judd Boczko, MD
Medical Advisor
Dr. Boczko is a board-certified urologist with over 25 years of clinical experience, specializing in robotic and minimally invasive treatments for prostate disease, kidney stones, and urologic cancers. He has led and participated in multiple clinical trials and brings a strong track record of scientific and patient-centered evaluation.In addition to his medical expertise, Dr. Boczko serves as Chief Investment Officer at Overlook Research & Investments, where he focuses on early-stage biotech and pharma. His rare combination of hands-on clinical insight and investment acumen makes him an invaluable contributor to AXC’s mission.At AxellaCoin, Dr. Boczko will help review and assess grant proposals, guide trial strategy, and ensure we fund projects with real-world impact.
Contact us
Email: [email protected]
⚖️ AXC Legal DisclaimerAxellaCoin (AXC) is a utility token created to support decentralized clinical research, including compassionate use programs and early-stage trials.AXC is not a security. It does not represent equity, ownership, dividends, or profit rights in any entity. It has not been registered under securities laws, and should not be acquired with an expectation of financial return.Utility Purposes Only:
- Support for trial funding initiatives
- Participation in Stake-to-Support campaigns
- Access to CRO services (future phase)
- Governance participation via DAO (future)When AXC is used to fund biotech startups, any resulting equity, warrants, or royalties are held by Axella Research or an affiliated treasury. These assets are not distributed to token holders, but may be used to reinvest in future research.This structure enables a sustainable funding ecosystem—not a profit-sharing scheme.The value of AXC may fluctuate. By using AXC, you acknowledge that it is a utility token, not a financial instrument, and is used at your own discretion.🏛️Disclosure on Token Valuation and Tax Treatment:AxellaCoin (AXC) is internally valued at $0.50 per token for the purposes of grant milestones, founder vesting schedules, and long-term project alignment. This valuation reflects AxellaCoin’s target price based on its utility, funding capacity, and projected growth.However, for tax, accounting, and regulatory purposes, all AXC transactions are recognized at their Fair Market Value (FMV) at the time of transaction. FMV is based on real-time market pricing as determined by publicly available decentralized exchanges (e.g., Minswap.io).Any grants issued, service payments made, or income received in AXC will be reported at FMV, regardless of the internal peg. This approach ensures compliance with IRS guidelines and supports transparent financial reporting across all stakeholders.Future white paper revisions, grant letters, and roadmap documents will consistently reflect this dual structure, citing both internal token valuation and FMV where applicable.
